Navigation Links
Amylin Pharmaceuticals Reports Third Quarter Financial Results
Date:10/19/2011

uarter ended September 30, 2011 from $70.0 million for the same period in 2010. The decrease primarily reflects lower expenses associated with BYDUREON pre-launch activities and a reduced cost structure associated with the Company's efforts to drive efficiencies in the business.  

Research and development expenses decreased to $46.6 million for the quarter ended September 30, 2011 from $51.2 million for the same period in 2010. The decrease reflects reduced spending for BYDUREON pre-launch inventory manufacturing, partially offset by increased spending on our metreleptin development program.  

Collaborative profit sharing, which represents Lilly's share of the gross margin for BYETTA, was $59.0 million for the quarter ended September 30, 2011, compared to $61.2 million for the same period in 2010.

Non-GAAP operating income was $13.0 million for the quarter ended September 30, 2011 compared to a non-GAAP operating loss of $16.1 million for the same period in 2010. Net loss excluding restructuring charges was $10.7 million, or $0.07 per share, for the quarter ended September 30, 2011, an improvement of 76% compared to $44.7 million, or $0.31 per share, for the same period in 2010. GAAP net loss was $13.2 million, or $0.09 per share, for the quarter ended September 30, 2011, compared to a GAAP net loss of $50.7 million, or $0.35 per share, for the same period in 2010.

Nine Months Ended September 30, 2011Total revenues for the nine months ended September 30, 2011 were $485.7 million. This includes net product sales of $460.7 million, including $385.1 million for BYETTA and $75.6 million for SYMLIN. This compares to net product sales of $488.8 million, consisting of $422.9 million for BYETTA and $65.9 million for SYMLIN for the same period in 2010.

Revenues under collaborative agreements were $25.0 million for the nine months ended September 30, 2011, and included a $15.0 million milestone payment from Lilly in connection
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amylin Pharmaceuticals to Webcast Third Quarter Results
2. Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
3. Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program
4. Amylin Pharmaceuticals to Webcast Second Quarter Results
5. U.S. District Court Rules in Favor of Lilly in Amylin Litigation
6. Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order
7. Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly
8. Lilly Comments on Court Ruling in Amylin Litigation
9. Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders
10. Lilly Provides Its Perspective in Response to Amylin Lawsuit
11. Lilly Provides Statement in Response to Amylin Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... , June 30, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-seven. ... the Company, commented, "We believe our current pipeline of ...
(Date:6/30/2015)... Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX ... the development and commercialization of Locilex® (pexiganan cream ... announced underwritten public offering of 1,480,000 shares of ... option in full to purchase an additional 222,000 ... proceeds to Dipexium are expected to be approximately ...
(Date:6/30/2015)... 2015  Today, the National Mobility Equipment Dealers Association ... Mobility Awareness Month Local Heroes Contest on National TV. ... that received 1.3 million votes. The sponsors for the ... Mobility , and Valley Honda Dealers , with ... Vantage Mobility International (VMI) and ElDorado Mobility ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Fifth ANDA Submission Of 2015 2Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... Aug. 2 Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused ... again been selected by leading dental industry magazine Dentistry Today as one ... 24th annual competition were published in the July issue.   , ... OraVerse is the first ...
... , ST. LOUIS ,  Aug. 2 K-V Pharmaceutical ... received notification from the New York Stock Exchange ("NYSE") on ... quantitative continued listing standards.  The NYSE informed the Company that ... criteria for the average closing price of a NYSE security ...
Cached Medicine Technology:OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 2OraVerse® Named as One of Dentistry Today's 'Top 100 Products' for Second Year 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 2K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 3K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 4K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 5K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 6K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 7K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 8K-V Pharmaceutical Company Notified by New York Stock Exchange of Non-Compliance With Continued Listing Standards 9
(Date:6/30/2015)... ... ... Trenton Health Team has been certified by the New Jersey Department of ... State, serving the greater Trenton community. The ACO pilot is for a three-year ... collaborative structure of THT, bringing together the vast majority of Trenton’s primary and specialty ...
(Date:6/30/2015)... ... 2015 , ... Retail Management Solutions is headed out to ... 29 to August 1. Retail Management Solutions will be attending along with pharmacy ... event for independent community pharmacies, where they receive practical and clinical knowledge, helping ...
(Date:6/30/2015)... ... 2015 , ... The American Lung Association in California announced its new partnership ... Speakers and clean air advocates included San Diego County Supervisor Ron Roberts, Dr. Atul ... Daniel Sullivan, founder and president of Sullivan Solar Power. , For every solar ...
(Date:6/30/2015)... ... 30, 2015 , ... University Post-Acute Rehab recently released a ... rehab center’s patients and their experiences at the facility. Medicare granted University Post-Acute ... Each patient attests to the high rating, which is predominantly based on cleanliness, ...
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... According to ... received a $3.1 million grant to study how sensory stimuli can be used to ... emphasis on improving care for children with autism, will compare patient experience in a ...
Breaking Medicine News(10 mins):Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 2Health News:Trenton Health Team Certified as Medicaid Accountable Care Organization 3Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 2Health News:Retail Management Solutions to Attend Amerisource's ThoughtSpot 2015 Conference and Trade Show 3Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 2Health News:Local Dignitaries Gather to Announce San Diego’s Clean Air Challenge 3Health News:Patients of University Post-Acute Rehab Support Five-Star Rating in New Video 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 2Health News:New Study Aims to Determine if Sensory Stimuli can Ease Dental Anxiety in Children, Notes Medical Center Dental Care 3
... housework and even though the housewife who does it is ... cancer. ,A research that surveyed 200,000 women from ... protective than playing sport. ,It has been long ... perhaps through hormonal and metabolic changes. ,Dusting, mopping ...
... War between scientists and bacteria has been going on for ... hand when they come up with a new anti-biotic that// ... celebrations are still going on, different resistant strains make an ... seems that a team of scientists at the Weizmann Institute ...
... risk factor for cardiovascular diseases.,A potbelly indicates that the risk ... of the body is skinny as a beanpole. ... is the relationship of waist size to the hips, an ... ,The study implies that even people who would otherwise be ...
... begun. Breakfast may soon be trimmings of cloned pig’s bacon, a ... beef or goat burger; ‘Frankenstein foods’, as some// refer to it. ... Administration (FDA) of US is getting ready to pass a bill ... our decision on looking at the health of the animal,” says ...
... in 2002, at the San Francisco's 2002 Gay Pride, San ... to popularize syphilis testing. ,In the above said ... to Gayville, encouraging the many hundreds of homo whores who ... (Syphilis) ,Although many were not happy with the ...
... company claimed to have developed a weight reduction pill, which ... cut the risk of heart disease, diabetes and cancer. ... 10 percent when taken for a year. ,But ... Californian biopharmaceutical firm Orexigen for 48 weeks lost 12 percent ...
Cached Medicine News:Health News:Household Chores May Reduce Risk Of Breast Cancer 2Health News:Scientists Come Up With A Powerful Weapon To Fight Drug Resistant Bacteria 2Health News:Pot Belly Is A Better Risk Predictor Of Heart Attack Than BMI 2Health News:Clones On the Menu 2
... The MicroAire® Hi Speed Pulse Lavage ... bone surfaces as well as cleansing ... Now a great system just got ... effective with the addition of ...
... Staple is a novel shape memory alloy bone ... of its Nitinol construction, the prongs of the ... upon application of a heating current. This results ... response of bone and cause adjustable compression across ...
... deformity of the ankle joint with ... fusion of the ankle joint, fractures ... where reconstruction is impossible, and fracture/dislocations ... severe arthritic changes and loss of ...
The Buechel-pappas™ Total Ankle Replacement is a time-tested system which is the result of more than twenty years of development, clinical investigation, and use. The components have been avai...
Medicine Products: